Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
AstraZeneca
Institut du Cancer de Montpellier - Val d'Aurelle
Eli Lilly and Company
Institut du Cancer de Montpellier - Val d'Aurelle
National Cancer Institute (NCI)
Aminex Therapeutics, Inc.
University of Southern California
Nuvation Bio Inc.
Centre Hospitalier Universitaire de Besancon
Weill Medical College of Cornell University
Southwest Hospital, China
Chinese PLA General Hospital
BBB-Therapeutics B.V.
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Envita Medical Center, Inc.
TransMolecular
Thallion Pharmaceuticals